Latest news
IMR: U.S. launch, regulatory wins, and new verticals set stage for accelerated growth in 2H 2026 - TradingViewTradingView · Sun, 09 Aug 2026 23:52:12 GMTIMR: Four FDA clearances, U.S. launch, and strong cash position set stage for growth in 2H26 - TradingViewTradingView · Sun, 09 Aug 2026 23:01:34 GMTIMR: U.S. launch, regulatory wins, and new verticals set stage for revenue inflection and growth - TradingViewTradingView · Sun, 09 Aug 2026 00:42:00 GMTIntellia Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 06:04:09 GMTNatera Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 06:04:00 GMTAGEN: Q2 revenue up 34% year-over-year; $85M financing supports pivotal ROBBIN trial launch - TradingViewTradingView · Thu, 06 Aug 2026 13:33:10 GMTSonoma Pharmaceuticals, Inc. Q1 2027: Revenue $6.41M, EPS $(0.09) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:41:00 GMTAMLX: LUCIDITY trial for avexitide nears topline data; cash runway extends into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:57 GMT